NASDAQ

Apogee Therapeutics, Inc. (APGE)

♥ 720 Thanks from members

Live price chart, market sentiment, and community perspectives for Apogee Therapeutics, Inc. (NASDAQ: APGE).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Apogee Therapeutics TeamLeadership: Michael Henderson (CEO)Leadership: Markus Enzelberger (CSO)Holder: PerkinElmer VenturesHolder: Fidelity ManagementHolder: RA Capital ManagementAPG777 (IL-13 inhibitor)APG808 (IL-4R alpha inhibitor)#APGE#Apogee Therapeutics#Biotech IPO#Immunology Biologics#NASDAQ Biotech